Explore the GLP-1 treatments available through CaliberRx. Each is prescribed by licensed clinicians when
clinically appropriate. After reviewing your medical history, your provider determines which option, if any, is
right for you.
Our provider-guided programs make medical weight loss simple, private, and convenient — helping you stay consistent and focused on results.

Connect anytime with licensed support.

Treatment based on your goals and needs.

No appointments or waiting rooms

We support you throughout your journey.
Start Now
Unlock a healthier future with provider-guided GLP-1 care. Check eligibility now and begin your transformation.
Compounded tirzepatide is prescribed by licensed clinicians through CaliberRx’s telehealth platform when clinically appropriate.
Your provider reviews your medical history and individualized assessment.
Individual results vary.
Tirzepatide is a dual GLP-1 / GIP receptor agonist — it engages two hormonal pathways involved in appetite signaling and blood sugar regulation. Through CaliberRx, compounded tirzepatide is prescribed by licensed clinicians when clinically appropriate. Your provider reviews your medical history and individualized health picture to decide whether a compounded GLP-1 medication fits your treatment plan.
Compounded semaglutide is prescribed by licensed clinicians through CaliberRx’s telehealth platform when clinically appropriate.
Your provider reviews your medical history and individualized assessment to determine whether a compounded GLP-1 medication is appropriate for you.
Individual results vary. Outcomes depend on many factors including diet, physical activity, medical history, and adherence to your treatment plan.
Compounded semaglutide is prescribed by licensed clinicians through CaliberRx’s telehealth platform when clinically appropriate. Semaglutide is a GLP-1 receptor agonist. Your provider will determine whether a compounded GLP-1 medication is appropriate for you based on your medical history and individualized assessment. Individual results vary.